DGI:Opportunistische Infektionen/Kryptokokkose/Weiterführende Literatur und Hilfestellungen - Revision history

imported>Fuhrmanns at 10:09, 23 November 2021

2021-11-23T10:09:24Z

← Older revision		Revision as of 10:09, 23 November 2021
Line 1:		Line 1:
	~~==Weiterführende Literatur und Hilfestellungen==~~
	1. Nelson M, Dockrell D, Edwards S, et al. British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. HIV Med. 2011;12 Suppl 2:1-140. doi:10.1111/j.1468-1293.2011.00944_1.x		1. Nelson M, Dockrell D, Edwards S, et al. British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. HIV Med. 2011;12 Suppl 2:1-140. doi:10.1111/j.1468-1293.2011.00944_1.x

imported>Bestem: Bestem verschob die Seite DGI:Kryptokokkose/Weiterführende Literatur und Hilfestellungen nach DGI:Opportunistische Infektionen/Kryptokokkose/Weiterführende Literatur und Hilfestellungen

2021-11-23T09:40:30Z

Bestem verschob die Seite DGI:Kryptokokkose/Weiterführende Literatur und Hilfestellungen nach DGI:Opportunistische Infektionen/Kryptokokkose/Weiterführende Literatur und Hilfestellungen

← Older revision		Revision as of 09:40, 23 November 2021
(No difference)

imported>Bestem: /* Weiterführende Literatur und Hilfestellungen */

2021-11-07T17:03:34Z

Weiterführende Literatur und Hilfestellungen

← Older revision		Revision as of 17:03, 7 November 2021
Line 1:		Line 1:
	== Weiterführende Literatur und Hilfestellungen ==		==Weiterführende Literatur und Hilfestellungen==
	1~~) A European Confederation~~ of ~~Medical Mycology Score Derived From Current Guidelines to Measure QUALity of Clinical Cryptococcosis Management~~. ~~''Open Forum Infect Dis~~. ~~''2018~~.		1. Nelson M, Dockrell D, Edwards S, et al. British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. HIV Med. 2011;12 Suppl 2:1-140. doi:10.1111/j.1468-1293.2011.00944_1.x

	2~~) British HIV Association and British Infection Association guidelines~~ for the ~~treatment~~ of ~~opportunistic infection in HIV-seropositive individuals 2011~~. ~~''HIV Med~~. ~~''2011~~.		2. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America \| Clinical Infectious Diseases \| Oxford Academic. Accessed November 7, 2021. <nowiki>https://academic.oup.com/cid/article/50/3/291/392360</nowiki>

	3~~) WHO~~-~~Guidelines for The Diagnosis~~, ~~Prevention and Management of Cryptococcal Disease in HIV-Infected Adults~~, ~~Adolescents and Children~~: ~~Supplement~~ to ~~the 2016 Consolidated Guidelines on the Use~~ of ~~Antiretroviral Drugs for Treating and Preventing HIV Infection~~.		3. Spec A, Mejia-Chew C, Powderly WG, Cornely OA. EQUAL Cryptococcus Score 2018: A European Confederation of Medical Mycology Score Derived From Current Guidelines to Measure QUALity of Clinical Cryptococcosis Management. Open Forum Infect Dis. 2018;5(11):ofy299. doi:10.1093/ofid/ofy299

	4~~) Southern African HIV Clinicians Society guideline~~ for the prevention~~, diagnosis~~ and management of cryptococcal disease ~~among~~ HIV-infected ~~persons~~: ~~2019 update~~. ~~''South Afr J HIV Med~~.''		4. Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. Accessed November 7, 2021. <nowiki>https://www.who.int/publications-detail-redirect/9789241550277</nowiki>

	''5~~) ''Clinical practice guidelines~~ for the ~~management~~ of ~~cryptococcal disease~~: ~~2010 update by the infectious diseases society of america. ''Clin Infect Dis. ''2010~~.		5. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents. :495.

	''6~~) ''HIV-associated opportunistic infections~~ of ~~the CNS~~. ~~''Lancet Neurol~~. ~~''2012~~.		6. Guidelines for the Prevention and Treatment of Opp.pdf. Accessed November 7, 2021. <nowiki>https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Adult_OI.pdf</nowiki>

	''7) ~~''Panel on Opportunistic Infections in Adults and Adolescents with~~ HIV~~. Guidelines~~ for the prevention and ~~treatment~~ of ~~opportunistic infections in adults and adolescents with~~ HIV: ~~recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the~~ HIV ~~Medicine Association of the Infectious Diseases Society of America~~.		7. Tan IL, Smith BR, von Geldern G, Mateen FJ, McArthur JC. HIV-associated opportunistic infections of the CNS. Lancet Neurol. 2012;11(7):605-617. doi:10.1016/S1474-4422(12)70098-4

			8. Govender NP, Meintjes G, Mangena P, et al. Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update. South Afr J HIV Med. 2019;20(1):1030. doi:10.4102/sajhivmed.v20i1.1030

			<br />

imported>Bestem: Die Seite wurde neu angelegt: „== Weiterführende Literatur und Hilfestellungen == 1) A European Confederation of Medical Mycology Score Derived From Current Guidelines to Measure QUALity of…“

2021-01-21T09:59:39Z

Die Seite wurde neu angelegt: „== Weiterführende Literatur und Hilfestellungen == 1) A European Confederation of Medical Mycology Score Derived From Current Guidelines to Measure QUALity of…“

New page

== Weiterführende Literatur und Hilfestellungen ==
1) A European Confederation of Medical Mycology Score Derived From Current Guidelines to Measure QUALity of Clinical Cryptococcosis Management. ''Open Forum Infect Dis. ''2018.

2) British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. ''HIV Med. ''2011.

3) WHO-Guidelines for The Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children: Supplement to the 2016 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection.

4) Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update. ''South Afr J HIV Med.''

''5) ''Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. ''Clin Infect Dis. ''2010.

''6) ''HIV-associated opportunistic infections of the CNS. ''Lancet Neurol. ''2012.

''7) ''Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.